Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis.
about
Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancerEBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistanceKallikreins as biomarkers for prostate cancerThe ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-AnalysisHuman tissue kallikreins: a new enzymatic cascade pathway?Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markersThe androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells.The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.Part 1: The burden of prostate cancer, its natural history, information on the outcome of screening and estimates of ad hoc screening with particular reference to England and Wales.Prognostic value of serum markers for prostate cancer.Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.Kallikreins - The melting pot of activity and functionProstate cancer markers: An update.Blood biomarkers for prostate cancer detection and prognosis.New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer.Screening for prostate cancer: an update.Risk-based prostate cancer screening.Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA).Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3.Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection.An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis: results of a 5-year investigation.Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsySerum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer
P2860
Q24290337-F763DC59-8395-41B1-96B8-FAC3C2970895Q24646417-5CD56D94-59DE-4C3A-840A-66E8F597570CQ26862434-6096BEDE-8112-4344-B801-25322A24DC23Q33896008-71549875-E0A2-4057-A323-F9F2D58D85FCQ34447102-69A45355-EB24-4D09-8EBC-018791B83043Q34793249-05FB866A-E2F7-40DC-BA45-7D239351AA88Q35000702-02D325B8-34FF-44EC-BCD6-250E8EB63030Q35032198-259AAB25-6328-4490-80F0-CCBD0E41E1B3Q35758327-EFBAC979-DB24-4324-AD44-FF63DC44A084Q35861497-5122B04A-260E-4756-A6D5-6B4B3724269BQ36103672-E2A75407-3DF3-4B99-A17B-CFC414C8FBFCQ36194964-A4BBC4D1-3D00-43C4-9AAC-10C2358CEB8BQ36266738-09CB3B8C-8288-43A1-9FD1-E09F78538017Q36563056-8F4728CA-DC01-4F19-9C7D-F0561E189EFCQ36640109-5F2FD5F5-8CDA-4FBD-BAC2-B457A9169A8BQ36895818-F04A20D4-0BA6-4FB8-BD84-A47A47E93100Q36973830-1C5BFF82-F000-4464-A5FE-E75F9EA38098Q37338478-9FEA6A90-C563-46D2-9270-5DA2B5D9E19EQ37963657-78FF0AED-0524-4437-8F43-E5F979CDD56EQ39678142-6D9E530D-D45D-4EA2-8698-842BAEE9C3EBQ40717386-DE263C51-BD2C-4D0F-9557-C5FECD7328D3Q40736593-4585B940-3E15-4D7C-8744-47446EF2D377Q51966359-D895C3CF-9C7B-490A-B82C-AB485525C307Q52041137-B48F696F-27F5-40E4-9339-1603E8FFF949Q57239036-BE206FB1-FBE2-4229-92B2-753334DF091BQ57941968-ADFFF821-6A4F-4AFD-8522-557D773A3957
P2860
Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Use of human glandular kallikr ...... cancer: preliminary analysis.
@en
type
label
Use of human glandular kallikr ...... cancer: preliminary analysis.
@en
prefLabel
Use of human glandular kallikr ...... cancer: preliminary analysis.
@en
P2093
P1433
P1476
Use of human glandular kallikr ...... cancer: preliminary analysis.
@en
P2093
Catalona WJ
Rittenhouse HG
Tindall DJ
Wolfert RL
Woodrum DL
P304
P356
10.1016/S0090-4295(99)00270-8
P407
P577
1999-11-01T00:00:00Z